Sökning: WFRF:(Vaduganathan Muthiah)
> (2021) >
Heart failure drug ...
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk : a multinational observational study (US, UK and Sweden)
-
- Savarese, Gianluigi (författare)
- Karolinska Institutet
-
- Bodegard, Johan (författare)
- AstraZeneca, Gothenburg, Sweden
-
- Norhammar, Anna (författare)
- Karolinska Institutet
-
visa fler...
-
- Sartipy, Peter (författare)
- Högskolan i Skövde,Institutionen för biovetenskap,Forskningsmiljön Systembiologi,AstraZeneca, Gothenburg, Sweden,Translationell bioinformatik, Translational Bioinformatics
-
- Thuresson, Marcus (författare)
- Statisticon, Uppsala, Sweden
-
- Cowie, Martin R. (författare)
- Faculty of Lifesciences & Medicine, King’s College London, London, UK ; Division of Guy’s & St Thomas’ NHS Foundation Trust, Royal Brompton Hospital, London, UK
-
- Fonarow, Gregg C. (författare)
- Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles Medical Center, Los Angeles, CA, USA
-
- Vaduganathan, Muthiah (författare)
- Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA
-
- Coats, Andrew J. S. (författare)
- University of Warwick, Coventry, UK ; Monash University, Clayton, Australia ; Pharmacology, Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana, Rome, Italy ; St George’s University of London, UK
-
visa färre...
-
(creator_code:org_t)
- 2021-06-28
- 2021
- Engelska.
-
Ingår i: European Journal of Heart Failure. - : John Wiley & Sons. - 1388-9842 .- 1879-0844. ; 23:9, s. 1499-1511
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://his.diva-por... (primary) (Raw object)
-
https://onlinelibrar...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims: Use and dosing of guideline-directed medical therapy (GDMT) in patients with heart failure (HF) have been shown to be suboptimal. Among new users of GDMT in HF, we followed the real-life patterns of dose titration and discontinuation of angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), beta-blockers, mineralocorticoid receptor antagonists (MRA) and angiotensin receptor-neprilysin inhibitors (ARNI).Methods and results: New users were identified in health care databases in Sweden, UK and US between 2016–2019. Inclusion criterion was a recent HF hospitalization (HHF) triggering the initiation of GDMT. Patients were grouped by GDMT, i.e. ACEi, ARB, beta-blocker, MRA and ARNI, and stratified by initial dose. Follow-up was 12 months, until death or study end. Outcomes were dose titration within each drug class, discontinuation and first HHF or death. Dose/discontinuation follow-up was assessed daily based on the coverage length of a filled prescription and reported on day 365. New users of ACEi (n = 8426), ARB (n = 2303), beta-blockers (n = 10 476), MRA (n = 17 421), and ARNI (n = 29 546) were identified. Over 12 months, target dose achievement was 15%, 10%, 12%, 30%, and discontinuation was 55%, 33%, 24% and 27% for ACEi, ARB, beta-blockers and ARNI, respectively. MRA was rarely titrated and discontinuation rates were high (40%). Event rates for HHF or death ranged from 40.0–86.9 per 100 patient-years across the treatment groups.Conclusion: Despite high risk of clinical events following HHF, new initiation of GDMT was followed by consistent patterns of low up-titration and early GDMT discontinuation in three countries with different health care and economies. Our data highlight the urgent need for moving away from long sequential approach when initiating HF treatment and for improving just-in-time decision support for patients and health care providers.
Ämnesord
- NATURVETENSKAP -- Biologi -- Bioinformatik och systembiologi (hsv//swe)
- NATURAL SCIENCES -- Biological Sciences -- Bioinformatics and Systems Biology (hsv//eng)
Nyckelord
- Angiotensin receptor blocker
- Angiotensin receptor–neprilysin inhibitor
- Angiotensin-converting enzyme inhibitor
- Beta-blocker
- Guideline-directed medical therapy
- Heart failure with reduced ejection fraction
- Mineralocorticoid receptor antagonist
- Bioinformatik
- Bioinformatics
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas